Literature DB >> 23281443

Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling.

Malte Sgodda1, Tobias Cantz.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23281443      PMCID: PMC3538324          DOI: 10.1038/mt.2012.273

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  20 in total

1.  Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells.

Authors:  Bryce W Carey; Styliani Markoulaki; Jacob H Hanna; Dina A Faddah; Yosef Buganim; Jongpil Kim; Kibibi Ganz; Eveline J Steine; John P Cassady; Menno P Creyghton; G Grant Welstead; Qing Gao; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

2.  Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Authors:  Eva Warlich; Johannes Kuehle; Tobias Cantz; Martijn H Brugman; Tobias Maetzig; Melanie Galla; Adam A Filipczyk; Stephan Halle; Hannes Klump; Hans R Schöler; Christopher Baum; Timm Schroeder; Axel Schambach
Journal:  Mol Ther       Date:  2011-02-01       Impact factor: 11.454

3.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells.

Authors:  Margaret A Young; David E Larson; Chiao-Wang Sun; Daniel R George; Li Ding; Christopher A Miller; Ling Lin; Kevin M Pawlik; Ken Chen; Xian Fan; Heather Schmidt; Joelle Kalicki-Veizer; Lisa L Cook; Gary W Swift; Ryan T Demeter; Michael C Wendl; Mark S Sands; Elaine R Mardis; Richard K Wilson; Tim M Townes; Timothy J Ley
Journal:  Cell Stem Cell       Date:  2012-04-26       Impact factor: 24.633

6.  Self-renewing endodermal progenitor lines generated from human pluripotent stem cells.

Authors:  Xin Cheng; Lei Ying; Lin Lu; Aline M Galvão; Jason A Mills; Henry C Lin; Darrell N Kotton; Steven S Shen; M Cristina Nostro; John Kim Choi; Mitchell J Weiss; Deborah L French; Paul Gadue
Journal:  Cell Stem Cell       Date:  2012-04-06       Impact factor: 24.633

7.  Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.

Authors:  Alexej Abyzov; Jessica Mariani; Dean Palejev; Ying Zhang; Michael Seamus Haney; Livia Tomasini; Anthony F Ferrandino; Lior A Rosenberg Belmaker; Anna Szekely; Michael Wilson; Arif Kocabas; Nathaniel E Calixto; Elena L Grigorenko; Anita Huttner; Katarzyna Chawarska; Sherman Weissman; Alexander Eckehart Urban; Mark Gerstein; Flora M Vaccarino
Journal:  Nature       Date:  2012-11-18       Impact factor: 49.962

8.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

9.  In vivo genome editing using a high-efficiency TALEN system.

Authors:  Victoria M Bedell; Ying Wang; Jarryd M Campbell; Tanya L Poshusta; Colby G Starker; Randall G Krug; Wenfang Tan; Sumedha G Penheiter; Alvin C Ma; Anskar Y H Leung; Scott C Fahrenkrug; Daniel F Carlson; Daniel F Voytas; Karl J Clark; Jeffrey J Essner; Stephen C Ekker
Journal:  Nature       Date:  2012-09-23       Impact factor: 49.962

10.  Targeting DNA With Fingers and TALENs.

Authors:  Daniel F Carlson; Scott C Fahrenkrug; Perry B Hackett
Journal:  Mol Ther Nucleic Acids       Date:  2012-01-24       Impact factor: 10.183

View more
  5 in total

1.  Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.

Authors:  Elena Matsa; Paul W Burridge; Kun-Hsing Yu; John H Ahrens; Vittavat Termglinchan; Haodi Wu; Chun Liu; Praveen Shukla; Nazish Sayed; Jared M Churko; Ningyi Shao; Nicole A Woo; Alexander S Chao; Joseph D Gold; Ioannis Karakikes; Michael P Snyder; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2016-08-18       Impact factor: 24.633

2.  Human iPSC derived disease model of MERTK-associated retinitis pigmentosa.

Authors:  Dunja Lukovic; Ana Artero Castro; Ana Belen Garcia Delgado; María de los Angeles Martín Bernal; Noelia Luna Pelaez; Andrea Díez Lloret; Rocío Perez Espejo; Kunka Kamenarova; Laura Fernández Sánchez; Nicolás Cuenca; Marta Cortón; Almudena Avila Fernandez; Anni Sorkio; Heli Skottman; Carmen Ayuso; Slaven Erceg; Shomi S Bhattacharya
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

3.  Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells.

Authors:  Wenli Yang; Ying Liu; Katherine J Slovik; Joseph C Wu; Stephen A Duncan; Daniel J Rader; Edward E Morrisey
Journal:  PLoS One       Date:  2015-08-17       Impact factor: 3.240

Review 4.  Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease.

Authors:  Kelly V Evans; Joo-Hyeon Lee
Journal:  Stem Cells Transl Med       Date:  2020-04-09       Impact factor: 7.655

5.  Using High-Content Screening to Generate Single-Cell Gene-Corrected Patient-Derived iPS Clones Reveals Excess Alpha-Synuclein with Familial Parkinson's Disease Point Mutation A30P.

Authors:  Peter Barbuti; Paul Antony; Bruno Santos; François Massart; Gérald Cruciani; Claire Dording; Jonathan Arias; Jens Schwamborn; Rejko Krüger
Journal:  Cells       Date:  2020-09-10       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.